1. Home
  2. OLMA vs SDA Comparison

OLMA vs SDA Comparison

Compare OLMA & SDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • SDA
  • Stock Information
  • Founded
  • OLMA 2006
  • SDA 2007
  • Country
  • OLMA United States
  • SDA China
  • Employees
  • OLMA N/A
  • SDA N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • SDA Blank Checks
  • Sector
  • OLMA Health Care
  • SDA Finance
  • Exchange
  • OLMA Nasdaq
  • SDA Nasdaq
  • Market Cap
  • OLMA 289.0M
  • SDA 337.0M
  • IPO Year
  • OLMA 2020
  • SDA N/A
  • Fundamental
  • Price
  • OLMA $5.28
  • SDA $2.66
  • Analyst Decision
  • OLMA Strong Buy
  • SDA
  • Analyst Count
  • OLMA 4
  • SDA 0
  • Target Price
  • OLMA $24.50
  • SDA N/A
  • AVG Volume (30 Days)
  • OLMA 688.0K
  • SDA 109.6K
  • Earning Date
  • OLMA 05-13-2025
  • SDA 05-19-2025
  • Dividend Yield
  • OLMA N/A
  • SDA N/A
  • EPS Growth
  • OLMA N/A
  • SDA N/A
  • EPS
  • OLMA N/A
  • SDA N/A
  • Revenue
  • OLMA N/A
  • SDA $458,905,000.00
  • Revenue This Year
  • OLMA N/A
  • SDA $61,121.51
  • Revenue Next Year
  • OLMA N/A
  • SDA N/A
  • P/E Ratio
  • OLMA N/A
  • SDA N/A
  • Revenue Growth
  • OLMA N/A
  • SDA 24.15
  • 52 Week Low
  • OLMA $2.86
  • SDA $2.41
  • 52 Week High
  • OLMA $16.62
  • SDA $11.74
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 60.00
  • SDA 36.86
  • Support Level
  • OLMA $4.80
  • SDA $2.64
  • Resistance Level
  • OLMA $5.61
  • SDA $2.90
  • Average True Range (ATR)
  • OLMA 0.38
  • SDA 0.34
  • MACD
  • OLMA 0.02
  • SDA -0.00
  • Stochastic Oscillator
  • OLMA 78.71
  • SDA 1.97

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About SDA SunCar Technology Group Inc.

SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform.

Share on Social Networks: